Companies: 49,246 Total Market Cap: 132591774254860.43

Sandoz Group AG

SWX-SDZ

Healthcare Drug Manufacturers - Specialty & Generic

Rank #1022

Market Cap 20.21 B

Volume 315,331

Price 47.68

Change (%) 1.61%

Country or region

Switzerland

Sandoz Group AG's latest marketcap:

20.21 B

As of 05/20/2025, Sandoz Group AG's market capitalization has reached $20.21 B. According to our data, Sandoz Group AG is the 1022th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	20.21 B
Revenue (ttm)	11.27 B
Net Income (ttm)	0
Shares Out	430.70 M
EPS (ttm)	0
Forward PE	14.16
Ex-Dividend Date	04/17/2025
Earnings Date	08/07/2025

Market Cap Chart

Data Updated: 05/20/2025

Sandoz Group AG's yearly market capitalization.

Sandoz Group AG has seen its market value grow from ₣11.66 B to ₣16.87 B since 2023, representing a total increase of 44.69% and an annual compound growth rate (CAGR) of 30.38%.

Date	Market Cap	Change (%)
05/20/2025	₣16.87 B	0.44%
12/30/2024	₣16.31 B	39.82%
12/29/2023	₣11.66 B

Company Profile

Sandoz Group AG Overview

Sandoz Group AG is a global leader in the development, manufacturing, and marketing of generic pharmaceuticals and biosimilars. Headquartered in Basel, Switzerland, the company has been a trusted name in the pharmaceutical industry since its founding in 1886.

Therapeutic Areas

Sandoz specializes in a wide range of therapeutic areas, including:

Cardiovascular
Central Nervous System
Oncology
Infectious Diseases
Pain and Respiratory
Diabetes
Immunology
Endocrinology
Hematology
Ophthalmology

Product Portfolio

The company offers a comprehensive portfolio of active pharmaceutical ingredients (APIs) and finished dosage forms, ensuring high-quality and accessible healthcare solutions worldwide.

Frequently Asked Questions

As of 05/20/2025, Sandoz Group AG (including the parent company, if applicable) has an estimated market capitalization of $20.21 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Sandoz Group AG global market capitalization ranking is approximately 1022 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Switzerland
Founded	1886
IPO Date	n/a
Employees	22,049
CEO	Richard Saynor
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Address	Centralbahnstrasse 4 Basel, 4051 Switzerland
Website	https://www.sandoz.com